QQ客服 官方微博 反馈留言

	Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial
	Wang, XuYi; Jiang, Haifeng; Zhao, Min; Li, Jing; Gray, Frank; Sheng, Lixia; Li, Yi; Li, Xiaodong; Ling, Walter; Li, Wei
	2019
卷号	11期号:1页码:e12344
关键词	buprenorphine-naloxone opiate dependence opiate substitution treatment People's Republic of China treatment efficacy
ISSN号	1758-5864
DOI	10.1111/appy.12344
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6345806
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, XuYi,Jiang, Haifeng,Zhao, Min,et al. Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial[J],2019,11(1):e12344.
APA	Wang, XuYi.,Jiang, Haifeng.,Zhao, Min.,Li, Jing.,Gray, Frank.,...&Hao, Wei.(2019).Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.,11(1),e12344.
MLA	Wang, XuYi,et al."Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial".11.1(2019):e12344.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。